) and mycobacteremia (0%-73%; ). Standard clinical management P ! .01 P ! .01 can improve outcomes in resource-poor settings.
tients admitted to general medical wards or patients referred to specialist infectious disease services. At admission or during clinical review on the wards, blood cultures were performed either for all patients or just for those who were febrile. Some studies have not included mycobacterial cultures. Although methods have differed markedly, a consistent pattern of infectious disease related to immunosuppression is emerging, in which high-grade bacterial and mycobacterial pathogens predominate and bloodstream invasion is common. Tuberculosis (TB) is of the greatest importance; it may often be disseminated at presentation and is increasingly recognized to be associated with mycobacteremia [1] [2] [3] [4] [5] .
Atypical mycobacteria can cause disseminated disease, but such infections are uncommon [2, 4] . Nontyphi Salmonella (NTS) septicemia is underrecognized and is associated with significant mortality, and invasive pneumococcal disease is a frequent and early manifesDownloaded from https://academic.oup.com/cid/article-abstract/33/2/248/325928 by guest on 27 January 2019 tation of HIV-related disease [3, [6] [7] [8] [9] [10] . Cryptococcosis appears to be an important bloodstream infection in some regions, but it appears to be less common in other areas and may be geographically variable [6] [7] [8] [9] . Toxoplasmosis may also be geographically variable [11, 12] . The other opportunistic infections characteristic of AIDS in temperate climates are rare [2, 12, 13] . These data are confirmed by cohort [14] and intervention studies [15, 16] at a few health care centers.
Such a pattern of disease is clearly different from that seen in Africans with HIV-AIDS living in the United Kingdom [17, 18] . Among these patients, opportunistic infections are far more common, and the spectrum of disease resembles that seen in UK-born patients. As the HIV epidemic has matured in Africa, it is possible that significant changes in the spectrum of clinical disease might occur, with patients experiencing more of the classic AIDS-defining problems and then presenting to the health services for diagnosis and treatment. Improvements in outcome may also be emerging, as doctors, patients, and their families become more knowledgeable about HIV-AIDS care. Such changes would have important implications for HIV-AIDS care services across sub-Saharan Africa [19] . Bacteremic infections can be reduced by cotrimoxazole prophylaxis, an intervention that may be effective in reducing both morbidity and mortality in at least some groups of HIV-infected adults [15, 16] . In contrast, polysaccharide pneumococcal vaccine appears to be ineffective [14] . In addition, there are still gaps in our knowledge of the etiology and clinical presentation of HIVrelated disease, especially disseminated Mycobacterium tuberculosis infection [1] [2] [3] [4] [5] 20] . However, no follow-up studies have been published that show how stable such a spectrum of disease is, or what has happened to outcome for specific HIV-related problems over time.
In 1988-1989, we carried out a cross-sectional survey of adults with HIV infection admitted to Kenyatta National Hospital (KNH; Nairobi, Kenya) [1, 6, 21] . The study was repeated in 1992 and again in 1997 on the same patient population over a similar time period and with the same methods, except for more extensive use of mycobacterial blood cultures in the 1992 and 1997 studies (this had not been feasible during the first study). The aim was to identify differences in the spectrum of clinical disease associated with the expanding and maturing HIV epidemic over the decade and to measure whether outcome for bloodstream infections (an unequivocal diagnostic category) had changed with time. Results describing the changing impact of HIV-AIDS on KNH are reported elsewhere [22, 23] .
PATIENTS AND METHODS
Study site. Nairobi is the capital city of Kenya and its main urban center. It is at a high altitude and is not an endemic area for malaria transmission. KNH is the main government hospital serving Nairobi and largely functions as a secondary-care provider, although it is also the national referral hospital. The adult medicine department has 8 teams, which accept patients over 24-h periods in rotation. There is a high turnover of junior staff members (3-month rotations), and senior staff members also move around; therefore, this study does not include the same clinical personnel over time. Placement of the research team was decided by the chair of the department of medicine, for logistic purposes; we are unaware of any bias in the process of team placement. Blood cultures were not routinely available during the study period. The survey periods were November 1988 to May 1989, February-June 1992 (with a 5-week gap in March-April for reasons unconnected with the study), and April-July 1997. The short rains usually fall in November and are followed by a cool season, then by the long rainy season in May and June.
Patients. Most people who visit KNH are poor urban dwellers with limited access to other health care providers and services. There was no public provision of any specific disease prophylaxis or antiretroviral therapy during the study period. All patients accepted for acute admission by one general medical team were recruited at admission by means of the same study protocol for each of 3 survey periods. Patients referred for specialist care were excluded, so the patient sample was representative of secondary-care users, the most common category of hospital users across Africa. Patients or their guardians were told that additional tests would be carried out for a range of infections, including malaria, typhoid, TB, and HIV infection. They were advised that there was no charge for additional tests, the results of which could help individual treatment; that the HIV test result would not be known until after discharge and would be anonymously linked to the study record only; that counseling and HIV testing was available if desired; that one extra blood test was necessary; and that there were no adverse consequences for nonparticipation.
Patients provided informed consent, along with a detailed history; then each patient was examined specifically for clinical features compatible with underlying immunosuppression (zoster scar, generalized lymphadenopathy, oral candida, oral hairy leukoplakia, chronic herpes simplex, and maculopapular pruritic skin rash) and was assessed with the World Health Organization AIDS surveillance case definition [24] . Temperature was recorded, and blood was drawn for culture and HIV serologic tests. For febrile patients, thick and thin blood films were prepared for microscopic examination for malaria. Mycobacterial blood cultures were performed for patients with temperatures у38ЊC or for whom active TB was suspected. Both pneumonia and TB were diagnosed by a combination of consistent clinical features at presentation, radiologic tests, culture, and therapeutic response. For patients with shock or fever, no focus of infection, and blood slides negative for malaria, an enteric fever-like illness was diagnosed [21] . Malaria was diagnosed by identifying trophozoites in blood films. All patients received standard clinical treatment and therapy and were followed-up until death or discharge. Final diagnoses were categorized by means of standard coding [21] [22] [23] . Definition of bloodstream infection. Bloodstream infections were defined as bacterial, mycobacterial, or fungal microorganisms isolated from culture of peripheral-blood samples and identified by standard techniques. Malaria was not included because it is invariably a bloodstream infection, regardless of the individual's HIV status.
Laboratory procedures.
Specimens were identified by study number alone and were processed with Oxoid (Unipath) media. Approximately 10 mL of blood was inoculated aseptically into 50-mL of brain-heart infusion broth enriched with 5% CO 2 . Cultures were subcultured onto blood and chocolate agar plates when turbid or, if clear, after 7 days. Terminal cultures also were plated onto Sabouraud dextrose agar. Isolates were identified by standard techniques. For mycobacterial culture, 2-3 mL of blood was added aseptically to 5 mL of selective Kirschner medium, was incubated at 37ЊC for 6 weeks, and then was subcultured to Lowenstein-Jensen medium for a further 6 weeks. Acid-fast colonies were subcultured. Atypical isolates were sent to the United Kingdom for speciation. Malaria slides (thick and thin films) were prepared from fingerprick specimens, were stained with Giemsa, and were examined in the study laboratory. HIV antibody testing was performed with Wellcozyme HIV-1 (Wellcome Diagnostics) and was confirmed with Enzynergost HIV (Behringwerk). Samples were con-1 ϩ 2 sidered to be positive only if dually reactive.
Data analysis. Data were analyzed or reanalyzed by SPSS (version 7.0 for Windows; SPSS) and Epi Info (version 6; Centers for Disease Control and Prevention) software. Comparisons between and within the 3 study periods were made using the x 2 test for categorical variables by the Mantel-Haenszel test for time trends and the Kruskal-Wallis 1-way analysis of variance test for continuous variables. Specific variables were compared by Fisher's exact test, where appropriate. Only 2-tailed comparisons were made.
RESULTS

Study site.
Over time, medical services at KNH have been reorganized. Since 1992, 80 general medical beds (27%) have been lost. The policy has remained never to refuse admission, so the rate of admission is not directly influenced by bed availability or staffing constraints. User charges were first introduced in December 1989 and were ongoing in 1992 and 1997. Automatic waivers for patients with HIV-AIDS and TB ceased in 1996, but anti-TB drugs remained free of charge. The Infectious Diseases Hospital in Nairobi was open throughout the decade. The conversion of Infectious Diseases Hospital into a general secondary care provider in Nairobi was not instituted in a practical sense until after completion of the study in late 1997. Medical teams had a comparable staffing complement during the study period, despite the rising number of admissions.
Patients. In 1988-1989, 506 patients were enrolled and Downloaded from https://academic.oup.com/cid/article-abstract/33/2/248/325928 by guest on 27 January 2019 Bacteremia. Community-acquired bacteremia was significantly associated with HIV status across the study (table 3) . In 1988-1989, 26.3% of HIV-positive patients had bacteremia, compared with 6.3% of HIV-negative patients (OR, 5.3; 95% CI, 3.0-9.4); in 1992, the rates were 24.3% versus 10.9% (OR, 2.63; 95% CI, 1.45-4.81) and in 1997, 13.7% versus 2.4% (OR, 6.56; 95% CI, 2.7-18.6). The higher proportion of HIV-negative patients with bacteremia seen in 1992, compared with that in 1988-1989, probably was related to a seasonal increase in cases of community-acquired pneumonia [22] and pneumococcal bacteremia (1.7% vs. 7.4%; OR, 4.6; 95% CI, 1.78-13.3). The rate decreased in 1997; only 1 case of pneumococcal bacteremia (0.3%) was identified in an HIV-negative patient. Significant seasonal changes in the rate were not seen among HIV-positive patients.
The number of HIV-positive patients presenting with fever and the rate of bacteremia decreased across the decade (table  3) . However, there was no change in the range of bacteria isolated from blood: NTS species and Streptococcus pneumoniae predominated throughout. HIV-positive patients with bacteremia also presented with consistent clinical features over the decade: a similar number were febrile at admission (78%-84%) and had signs of immunosuppression (56%-69%) or clinical AIDS (26%-34%). All HIV-positive patients with S. pneumoniae bacteremia presented with acute community-acquired pneumonia for which parenteral penicillin was standard therapy. In 1992, 1 patient also had pneumococcal meningitis. Most HIV-infected patients with gram-negative rod bacteremia in all 3 study periods presented with an enteric fever-like illness or with clinical typhoid [21] . Overall, of those presenting with NTS bacteremia, 76% (29 of 38) had enteric fever-like illness. Of the 38 NTS isolates, 37 (97%) were serovar typhimurium, and 1 was serovar enteritidis. Standard therapy for suspected gram-negative septicemia was either chloramphenicol or ampicillin with gentamicin. Dual infections were also recorded: in 1992, 1 patient presented with both NTS and S. pneumoniae bacteremia; in 1997, 1 patient with NTS bacteremia had concurrent mycobacteremia, and another had pulmonary TB.
Mycobacteremia. In the first study in 1988-1989, reagents for carrying out mycobacterial blood cultures were limited and were available only for the second half of the study period [1] . Consequently, we assessed 42 rather than all 95 HIV-positive adults, and 183 rather than all 411 HIV-negative adults. Of these, only 8 (19%) of 42 and 11 (6%) of 183, respectively, had mycobacterial blood cultures performed, because stricter screening criteria (because of suspected widespread TB) were used. In the latter 2 studies, more facilities were available and broader sampling criteria were used (i.e., fever or suspected active TB); thus, more patients met the sampling criteria. This was the case for 60% of HIV-positive patients in both 1992 and 1997 (88 and 115 patients, respectively) and for 28% and 41%, respectively, of HIV-negative patients. In the HIV-positive patients assessed in each study period, a similar proportion (21%-27%) had a final diagnosis of TB. In 1988-1989, 2 patients (4.8%) had mycobacteremia. With more active sampling, 7.6% of HIV-positive patients were found to have mycobacteremia in 1992 and also in 1997 (table  4) . Considering only HIV-positive patients diagnosed with active TB, the rate of mycobacteremia (20%-23%) were comparable across the decade. Most HIV-positive patients with mycobacteremia (50%-73%) in all 3 studies had overt, active pulmonary TB. In 1988-1989, 1 patient with mycobacteremia was also grossly wasted and had diarrhea (such patients are known as "slim" patients). In 1992, 6 patients with mycobacteremia (60%) presented with gross wasting, as did 7 patients (47%) in 1997. Other presentations included tuberculous meningitis, peritonitis, and pericardial, pleural, and miliary disease; and none of the patients could be considered to have true occult mycobacteremia. Most (78%-100%) patients had chest radiographs that showed abnormalities, and TB was the main differential diagnosis. Most (50%-73%) also had clinical AIDS. In wasted (slim) patients, the impression across the study periods was that disseminated TB was an acute agonal event associated with rapid clinical deterioration in wasted patients who had previously been relatively stable.
Other infections.
Cryptococcus neoformans was isolated from blood cultures in 1988-1989 and 1997 and from CSF cultures but not blood cultures in 1992; it was isolated only from HIV-positive patients. No other disseminated fungal infections were identified. In 1988, Plasmodium falciparum malaria was diagnosed in 1 (1.5%) of 65 of HIV-positive febrile patient. In 1992, 2 (1.4%) of 79 and, in 1997, 6 (5.9%) of 101 febrile HIV-positive patients had P. falciparum malaria. Concurrent bacteremia also was recorded in HIV-positive patients with slide-positive malaria (table 2) . No patients were seen in any study period who had clinical or radiographic presentations compatible with Pneumocystis carinii pneumonia, toxoplasma encephalitis, or cytomegalovirus retinitis.
Outcome.
The mortality rate for HIV-positive patients with bloodstream infections decreased significantly over the decade (table 2) . Breaking this down further, the mortality rate for HIV-related bacteremia decreased significantly from 58% in 1988-1989, to 40% in 1992, to 18.5% in 1997 ( ; table P ! .001 3); this was particularly marked for NTS bacteremia (from 80% to 33% to 17%, respectively;
). However, there was no P ! .01 significant trend in the mortality rate associated with pneumococcal bacteremia; overall, 20.7% (6 of 29) of patients with this serious life-threatening infection died. The mortality rate among HIV-negative patients with bacteremia also showed a downward trend, from 32% (8 of 25) in 1988-1989, to 24% (6 of 25) in 1992, to 14% (1 of 7) in 1997, but this trend was not statistically significant ( ). P p .32 The initial mortality rate among HIV-positive inpatients with mycobacteremia decreased 4-fold during the study period, from 100% in 1988-1989 and 1992 to 26.7% in 1997 ( ; table P ! .001 4). However, the survival rate among patients with mycobacteremia who presented with chronic wasting remained poor: it was 57% (4 of 7) in 1997. For smear-positive or severely ill extrapulmonary and smear-negative patients with TB, shortcourse therapy with rifampin, pyrazinamide, isoniazid, and ethambutol (replacing streptomycin, isoniazid, and thiacetazone) in the induction phase was implemented by 1997. Most patients with mycobacteremia began to received the new regimen in 1997 (12 of 13 who started TB therapy).
DISCUSSION
During the decade from 1988 through 1997 we carried out 3 similar cross-sectional studies of bloodstream infections in adult patients admitted to an urban African hospital. Both bacteremia and mycobacteremia were significantly associated with underlying HIV infection; infection with NTS, S. pneumoniae, and M. tuberculosis predominated. Fungemia was rare, and only C. neoformans was isolated. Although the rate of bacteremia decreased, the rate of mycobacteremia appeared to be more stable over the decade, and patients' clinical features at presentation remained similar. Significant improvement in the rate of survival among patients with bloodstream infections were seen over the course of the 3 studies, which is attributable to better recognition and, at least for TB, use of better standard therapy. These are encouraging signs that suggest that improvements in quality of care can be achieved for at least some groups of HIV-AIDS patients in a resource-constrained health service, even when pressures on acute-care hospital services have greatly increased.
Particular attention was given in our study to bloodstream infections because they are clearly strongly associated with HIV infection, are often life-threatening, and represent an unequivocal diagnostic category for which consistent and uniform screening can be carried out. We worked in one representative hospital throughout and included only acute admissions in our study sample; venipuncture was performed only at the time of presentation, before any therapy was provided. Furthermore, in our study protocol, consecutive patients were enrolled, few declined to participate, and relatively large numbers were investigated. No bias entered into the selection of HIV-positive patients, to our knowledge. Standard treatment alone was used. The trends and consistent observations described across the decade are likely to be relatively robust.
As expected, bacteremia and mycobacteremia both were significantly associated with underlying HIV infection. Apart from the probable influence of the late rains in 1992, which may have significantly elevated the number of HIV-negative patients with pneumococcal bacteremia [22] , the risk of bloodstream infection with HIV infection seemed similar in the 3 studies. It is not entirely clear why the rate of bacteremia in HIV-positive patients admitted to KNH has fallen over the decade while the rate for mycobacteremia has been more constant. Overall, significantly fewer HIV-positive patients had signs of underlying immunosuppression or clinical AIDS at admission in 1997, which has been attributed to changes in health-care-seeking behavior among chronically ill individuals in the community [23] . Bacteremia is more common among patients with advanced immunosuppression, so the reduction in the number of patients who presented with more advanced disease would explain such a trend. Furthermore, the subgroup of patients who had bacteremia at admission presented with a consistent pattern of clinical signs and symptoms. Patients with TB usually present with specific syndromes, especially chronic cough. The proportion of HIV-positive patients who were diagnosed with TB has not changed significantly over the decade. Indeed, if any trend is emerging, it is for more patients to present with TB, which suggests that health-care-seeking behavior in the community may be substantially different for cough than it is for fever or other chronic symptoms. Again, for whatever reason, because the number of patients with active TB who were seen did not change over the decade, the rate of mycobacteremia was stable, and the clinical profile of patients with mycobacteria was consistent; overall, 63% (17 of 27) had clinical AIDS at presentation.
With careful clinical observation, few cases of mycobacteremia go unrecognized, and occult disseminated TB probably is uncommon [2, 25] .
Apart from fungemia [7] , the spectrum of bloodstream infections we identified in HIV-positive patients is similar to that described elsewhere in sub-Saharan Africa [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Other groups have just conducted single cross-sectional studies, and it has not been clear whether this pattern of disease will change over time as the epidemic of HIV-AIDS disease matures. Because we used the same clinical screening, sampling techniques, and laboratory processing in all 3 studies, we can be fairly confident that the spectrum of high-grade bacterial and mycobacterial infections has been preserved during the decade in unselected acute medical patients who presented directly for care to the hospital. As the HIV epidemic has matured in Nairobi, there has been no evidence that the pattern of inpatient HIV-AIDS disease has changed, with more of the classic Western AIDS-associated opportunistic infections emerging. In Nairobi, and perhaps elsewhere, these results may have important implications for planning and preparing for the patients who present to the hospital services for treatment during the continued epidemic of HIV-AIDS disease [26] . Whether opportunistic infections are emerging in patients with end-stage disease in the community who eschew hospital attendance remains to be seen.
The present study has documented impressive improvements in the outcome for patients with bloodstream infections during the decade. It is possible that some of the increase in the survival rate among patients with bacteremia relates to the shift toward fewer immunosuppressed patients presenting for care. We were unable to measure either CD4 cell counts or virus loads for patients and thus cannot make any allowance for this potential confounding factor. However, clinical features suggest that the patients with bloodstream infections seen in the 3 studies were comparable with respect to the signs of HIV-related immunosuppression or clinical AIDS at admission and in the spectrum of organisms isolated. All received standard care and were treated according to routine treatment guidelines. A local Hawthorne effect on the observed ward seems to be unlikely. It seems more plausible that the impressive 3-fold reduction in mortality with bacteremia seen over the decade relates to improved recognition and prompt instigation of standard antimicrobial therapy and supportive treatment. Outside the study period, this appears to be achieved and sustained without routine or regular access to blood culture services. The even more dramatic improvement in survival with mycobacteremia can be linked to the use of rifampin-based short-course chemotherapy as standard first-line therapy, as well as prompt diagnosis and instigation of therapy.
Therefore, the potential to improve outcome and increase the survival rate clearly exists in resource-poor settings and is not predicated on having access to high-technology facilities or expensive nonessential therapy. We identified 2 problems related to HIV infection that are common and perhaps ubiquitous in poor tropical countries, NTS bacteremia and M. tuberculosis mycobacteremia, for which that potential improvement has been realized to an impressive extent at one health care center over the last decade. This appears to have been achieved with better knowledge and understanding of the HIV-AIDS disease process and through prompt implementation of standard care. The rate of bed occupancy rose alarmingly in 1997, to 190%, and no additional resources were devoted to KNH that can account for such impressive increase in the survival rate. The expectation must then be that this can be sustained.
We hope that other health care centers will be encouraged by these results and will strive also to improve outcome for treatable and curable events when patients present for care. Too often, depressing messages are heard about the HIV-AIDS epidemic in Africa, with little attention being paid to the substantial achievements that are being made, often with limited resources. Even with limited facilities and access only to standard therapy, good-quality clinical care can, at least in some institutions, directly improve survival for common HIV-related problems.
